Concomitant inhaled corticosteroid use and the risk of pneumonia in COPD: a matched-subgroup post hoc analysis of the UPLIFT® trial

BACKGROUND: Use of inhaled corticosteroids (ICS) increases the risk of pneumonia in chronic obstructive pulmonary disease (COPD), but the magnitude of risk with different ICS remains unclear. METHODS: A post hoc analysis of the 4-year UPLIFT® trial to assess whether pneumonia risk differed by type o...

Descripción completa

Detalles Bibliográficos
Autores principales: Tashkin, Donald P., Miravitlles, Marc, Celli, Bartolomé R., Metzdorf, Norbert, Mueller, Achim, Halpin, David M. G., Anzueto, Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6173940/
https://www.ncbi.nlm.nih.gov/pubmed/30290801
http://dx.doi.org/10.1186/s12931-018-0874-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6173940/
https://www.ncbi.nlm.nih.gov/pubmed/30290801
http://dx.doi.org/10.1186/s12931-018-0874-0

Ejemplares similares